Andrew von Eschenbach
Encyclopedia : A : AN : AND : Andrew von Eschenbach
Andrew von Eschenbach is acting commissioner of the Food and Drug Administration as of September 26 2005.
According to the White House, "Von Eschenbach was the Director of the Program Center for Genitourinary Cancers and the Director of the Prostate Cancer Research Center at the University of Texas M.D. Anderson Cancer Center in Houston, Texas. Additionally, he is the Special Assistant to the President of the M.D. Anderson Cancer Center for External Affairs, a Professor of Urology and Consulting Professor of Cancer Biology. Dr. von Eschenbach has served as a Professor at the University of Texas Medical School at Houston and the University of Texas Health Science Center at Houston. He has been a Member of the Board of Directors of the American Cancer Society since 1993, serving as Second Vice President, First Vice President. Dr. von Eschenbach is a graduate of St. Joseph's College and Georgetown University Medical School and a former member of the U.S. Navy."
Despite his appointment to the FDA, von Eschenbach initially wanted to retain his position of Director at the National Cancer Institute, where some have questioned his scientific objectivity.[[Citing sources citation needed]]
External links
- http://www.cancer.gov/directorscorner/about-the-director Official biography
- http://www.washingtonpost.com/wp-dyn/content/article/2005/09/25/AR2005092501001.html
From Wikipedia, the Free Encyclopedia. Original article here. Support Wikipedia by contributing or donating.
All text is available under the terms of the GNU Free Documentation License See Wikipedia Copyrights for details.